{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=REGN1033", "query": { "intervention": "REGN1033" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 6, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-19T15:45:08.495Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02741739", "title": "Study of the Blood Concentrations of Two Formulations of REGN1033 in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "REGN1033", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 28, "start_date": "2016-03", "completion_date": "2016-05", "has_results": false, "last_update_posted_date": "2016-10-14", "last_synced_at": "2026-09-19T15:45:08.495Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02741739" }, { "nct_id": "NCT01963598", "title": "Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sarcopenia" ], "interventions": [ { "name": "REGN1033 (SAR391786)", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "70 Years", "maximum_age": null, "sex": "ALL", "summary": "70 Years and older" }, "enrollment_count": 253, "start_date": "2013-11", "completion_date": "2015-02", "has_results": false, "last_update_posted_date": "2016-03-28", "last_synced_at": "2026-09-19T15:45:08.495Z", "location_count": 33, "location_summary": "Anniston, Alabama • Phoenix, Arizona • El Cajon, California + 30 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "El Cajon", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Laguna Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01963598" }, { "nct_id": "NCT01910220", "title": "Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "REGN1033 (SAR391786)", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 125, "start_date": "2013-08", "completion_date": "2014-10", "has_results": false, "last_update_posted_date": "2014-11-10", "last_synced_at": "2026-09-19T15:45:08.495Z", "location_count": 5, "location_summary": "Gainesville, Florida • Orlando, Florida • Boston, Massachusetts + 2 more", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Athens", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01910220" }, { "nct_id": "NCT06299098", "title": "A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "Trevogrumab-Part A", "type": "DRUG" }, { "name": "Trevogrumab-Part B and Part C", "type": "DRUG" }, { "name": "Garetosmab", "type": "DRUG" }, { "name": "Semaglutide", "type": "DRUG" }, { "name": "Matching Placebo-Part A", "type": "DRUG" }, { "name": "Matching Placebo-Trevogrumab", "type": "DRUG" }, { "name": "Matching Placebo-Garetosmab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 1005, "start_date": "2024-03-13", "completion_date": "2026-10-21", "has_results": false, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-09-19T15:45:08.495Z", "location_count": 58, "location_summary": "Anniston, Alabama • Cullman, Alabama • Phoenix, Arizona + 51 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Cullman", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06299098" }, { "nct_id": "NCT01507402", "title": "A Study to Assess the Safety and Tolerability of Single Ascending Doses of REGN1033(SAR391786)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "REGN1033(SAR391786)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 76, "start_date": "2012-01", "completion_date": "2012-11", "has_results": false, "last_update_posted_date": "2012-11-14", "last_synced_at": "2026-09-19T15:45:08.495Z", "location_count": 2, "location_summary": "Honolulu, Hawaii • Evansville, Indiana", "locations": [ { "city": "Honolulu", "state": "Hawaii" }, { "city": "Evansville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01507402" }, { "nct_id": "NCT01720576", "title": "Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1033 (SAR391786)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "REGN1033 (SAR391786)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 60, "start_date": "2012-10", "completion_date": "2013-06", "has_results": false, "last_update_posted_date": "2013-09-12", "last_synced_at": "2026-09-19T15:45:08.495Z", "location_count": 2, "location_summary": "Daytona Beach, Florida • Evansville, Indiana", "locations": [ { "city": "Daytona Beach", "state": "Florida" }, { "city": "Evansville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01720576" } ] }